Position in NVAX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$290,880
-$576,086 QoQ
Shares Held
30,879
-71.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#116
of 263 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $324,055,173 across 66 Biotechnology names. NVAX ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
174,812 | $86,834,364 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,307,514 | $73,312,309 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,523 | $40,856,211 | |
| 4 | INCY |
Incyte Corp
|
312,130 | $35,383,056 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,646 | $28,190,254 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
65,240 | $12,218,147 | |
| 7 | INSM |
INSMED Inc
|
91,077 | $9,710,629 | |
| 8 | EXEL |
Exelixis, Inc.
|
170,171 | $9,259,004 |
All Filings in NVAX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $290,880 | 30,879 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $866,966 | 106,507 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $599,303 | 89,182 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $295,404 | 34,072 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $426,642 | 67,721 | Shares | Defined | 2025-08-08 | |
| 2022-03-31 | $2,511,832 | 34,105 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,168,403 | 36,125 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $8,351,897 | 40,287 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,609,382 | 40,551 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||